N. F. Aykan Et Al. , "Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy," MEDICAL ONCOLOGY , vol.30, no.3, 2013
Aykan, N. F. Et Al. 2013. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy. MEDICAL ONCOLOGY , vol.30, no.3 .
Aykan, N. F., Yildiz, I., Sen, F., Kilic, L., Keskin, S., Ciftci, R., ... Karabulut, S.(2013). Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy. MEDICAL ONCOLOGY , vol.30, no.3.
Aykan, N. Et Al. "Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy," MEDICAL ONCOLOGY , vol.30, no.3, 2013
Aykan, N. F. Et Al. "Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy." MEDICAL ONCOLOGY , vol.30, no.3, 2013
Aykan, N. F. Et Al. (2013) . "Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy." MEDICAL ONCOLOGY , vol.30, no.3.
@article{article, author={N. Faruk Aykan Et Al. }, title={Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy}, journal={MEDICAL ONCOLOGY}, year=2013}